Diseases, Conditions, Syndromes

Nintedanib slows progression for broad range of scarring lung diseases

Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases. The findings, published in the New England ...

Diseases, Conditions, Syndromes

Self-monitoring solution in mobile app can help uncontrolled asthma

A study by researchers at Karolinska Institutet shows that a treatment-adjustment algorithm based on lung function and symptoms in a mobile phone is useful for managing uncontrolled asthma. For fuss-free measuring of lung ...

Diseases, Conditions, Syndromes

Ivacaftor may reduce common infections in patients with CF

Patients with cystic fibrosis who take ivacaftor appear to have fewer respiratory infections over time than those not taking the drug, according to new research published online in the Annals of the American Thoracic Society.

Diseases, Conditions, Syndromes

COPD may strike women harder than men

(HealthDay)—Women with chronic obstructive pulmonary disease (COPD) appear to have a harder time than men with the progressive lung disorder, a new study suggests.

page 10 from 40